{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:21:06Z","timestamp":1778556066900,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ejphar.2010.06.035","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T04:36:28Z","timestamp":1278477388000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Actions of thalidomide in producing vascular relaxations"],"prefix":"10.1016","volume":"644","author":[{"given":"Sai Wang","family":"Seto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria","family":"Bexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Aiden","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.06.035_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0090-6980(01)00098-3","article-title":"Regulation of prostacyclin synthesis by angiotensin II and TNF-\u03b1 in vascular smooth muscle","volume":"263","author":"Askari","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0010","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1200\/JCO.2000.18.14.2710","article-title":"Phase II evaluation of thalidomide in patients with metastatic breast cancer","volume":"18","author":"Baidas","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/HYPERTENSIONAHA.108.125831","article-title":"Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade","volume":"53","author":"Ball","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0020","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0006-2952(98)00046-X","article-title":"Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent","volume":"55","author":"Bauer","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2680.1999.00149.x","article-title":"Vascular actions of 17\u03b2-oestradiol in rat aorta and mesenteric artery","volume":"19","author":"Browne","year":"1999","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/HCO.0b013e3282fbfbc7","article-title":"Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?","volume":"23","author":"Celis","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(82)90159-5","article-title":"[3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of \u03b12-adrenoceptors","volume":"84","author":"Cheung","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1474-8673.2004.00317.x","article-title":"Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle","volume":"24","author":"Cleary","year":"2004","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/paa.1999.111.5.429","article-title":"Voltage-gated T-type Ca2+ channels and heart failure","volume":"111","author":"Clozel","year":"1999","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1476-5381.1990.tb12702.x","article-title":"Functional evidence for heterogeneity of peripheral prejunctional \u03b12-adrenoceptors","volume":"101","author":"Connaughton","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0060","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/j.1552-4604.1998.tb04804.x","article-title":"The relevance of T-type calcium antagonists: a profile of mibefradil","volume":"38","author":"Glasser","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0065","first-page":"73","article-title":"Increased contractile responses to endothelin-1 and U46619 via a protein kinase C-mediated nifedipine-sensitive pathway in diabetic rat aorta","volume":"104","author":"Hattori","year":"1999","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1254\/jphs.FMJ05002X6","article-title":"Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation","volume":"99","author":"Hayashi","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0080","first-page":"417","volume":"40","author":"Hefti","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0085","first-page":"4","article-title":"Influence of dimethyl sulfoxide (Me2SO) on vascular smooth muscle","volume":"237","author":"Jackson","year":"1979","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9r."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dot.2004.40.3.820083","article-title":"The promise of thalidomide: evolving indications","volume":"40","author":"Joglekar","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1734-1140(09)70040-4","article-title":"Contribution of NO, ATP-sensitive K+ channels and prostaglandins to adenosine receptor agonists-induced relaxation of the tail artery","volume":"61","author":"Kedzior","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0100","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.RES.0000225862.14314.49","article-title":"Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1\/1\u03b11G T-type calcium channels","volume":"98","author":"Mangoni","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0105","doi-asserted-by":"crossref","first-page":"H2282","DOI":"10.1152\/ajpheart.00544.2002","article-title":"Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists","volume":"283","author":"Massett","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2004.08.053","article-title":"Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels","volume":"103","author":"Mayer","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/j.1939-4640.2001.tb02222.x","article-title":"Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway","volume":"22","author":"McAuley","year":"2001","journal-title":"J. Androl."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000049097","article-title":"Is postural hypotension a real problem with antihypertensive medication?","volume":"96","author":"Meredith","year":"2001","journal-title":"Cardiology"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1476-5381.1989.tb14617.x","article-title":"Identification of a single \u03b11-adrenoceptor corresponding to the \u03b11A-subtype in rat submaxillary gland","volume":"98","author":"Michel","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor \u03b1 by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2006.06.049","article-title":"Characterisation of the relaxant response to raloxifene in porcine coronary arteries","volume":"545","author":"Moritz","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1085\/jgp.74.1.85","article-title":"The active tension-length curve of vascular smooth muscle related to its cellular components","volume":"74","author":"Mulvany","year":"1979","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1476-5381.1985.tb08868.x","article-title":"[3H]-rauwolscine binding to \u03b12-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species","volume":"85","author":"Neylon","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000096829","article-title":"Effects of thalidomide treatment in heart failure patients","volume":"108","author":"Orea-Tejeda","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0155","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2146\/ajhp070029","article-title":"Lenalidomide in the treatment of multiple myeloma","volume":"64","author":"Rao","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200565002-00002","article-title":"Vascular effects of calcium channel antagonists: new evidence","volume":"65","author":"Richard","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0165","series-title":"Effects of T-type Calcium Channel Blockers and Thalidomide on Contractions of Rat Vas Deferens","author":"Seto","year":"2009"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejphar.2005.12.038","article-title":"Modulatory effect of interleukin-1beta on rat isolated basilar artery contraction","volume":"531","author":"Seto","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0175","series-title":"Investigation of Vascular Relaxations Produced by Thalidomide","author":"Seto","year":"2009"},{"key":"10.1016\/j.ejphar.2010.06.035_bb0180","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1152\/jappl.1993.74.4.1905","article-title":"Pulmonary and systemic vascular responsiveness to TNF-\u03b1 in conscious rats","volume":"74","author":"Stevens","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1152\/japplphysiol.00210.2009","article-title":"Hindlimb unweighting induces changes in the p38MAPK contractile pathway of the rat abdominal aorta","volume":"107","author":"Summers","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-007-0521-9","article-title":"Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors","volume":"61","author":"Varker","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","article-title":"The role of thalidomide in the management of erythema nodosum leprosum","volume":"78","author":"Walker","year":"2007","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0200","first-page":"H1361","article-title":"Two types of calcium channels in isolated smooth muscle cells from rat tail artery","volume":"256","author":"Wang","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2010.06.035_bb0205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1381612053382179","article-title":"Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation","volume":"11","author":"Yasui","year":"2005","journal-title":"Curr. Pharm. Des."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910006266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910006266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:11:58Z","timestamp":1757974318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910006266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0014299910006266"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.06.035","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actions of thalidomide in producing vascular relaxations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}